Himax Technologies, Inc. HIMX
Set alert
10.78 USD +0.33 +3.11%
As of Nov 3, 10:42 AM ET
10.60 Day range 10.82
6.85 52-week range 25.09
- YTD
- +31.56%
- 1 year
- +15.86%
- Open
- 10.65
- Prev close
- 10.45
- Mkt cap
- 1.88B
- Vol
- 130.91K
- Avg vol
- 1.14M
- EPS
- 0.21
- P/E
- 51.31
- Div yield
- 2.07%
More statistics
- Low
- 10.60
- High
- 10.82
- Forward P/E
- 8.04
- Beta
- 2.51
- Short ratio
- 2.86
- Inst. own
- 24.62%
- Dividend
- 0.25
- Ex-div date
- Jun 29, 2026
- Earnings
- Nov 5, 2026
- 50-d avg
- 13.32
- 200-d avg
- 12.76
- 1y target
- 30.20
5D chart
Signals (95)
| Name | Time | Ago |
|---|---|---|
| RSI: Overbought | Oct 30, 3:45 PM | 3 days ago |
| RSI: Overbought | Oct 30, 3:20 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:05 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:55 PM | 3 days ago |
| RSI: Oversold | Oct 30, 2:15 PM | 3 days ago |
| RSI: Oversold | Oct 30, 1:50 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:40 PM | 3 days ago |
| RSI: Oversold | Oct 30, 1:30 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 1:15 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 1:10 PM | 3 days ago |
| SMA: Bearish | Oct 30, 11:00 AM | 4 days ago |
| RSI: Oversold | Oct 30, 11:00 AM | 4 days ago |
| MACD: Buy Signal | Oct 30, 10:45 AM | 4 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 4 days ago |
| MACD: Sell Signal | Oct 30, 9:30 AM | 4 days ago |
| RSI: Oversold | Oct 30, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 29, 3:30 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 3:20 PM | 4 days ago |
| RSI: Oversold | Oct 29, 2:30 PM | 4 days ago |
Newest 20 of 95.
Analyst view
Consensus: buy
Buy
Price target (mean) 30.20 +180.3% upside
Now 10.78
- Target (low)
- 17.40
- Target (mean)
- 30.20
- Target (high)
- 43.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
- Strong buy0
- Buy2
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.09 | 0.09 – 0.09 | 0.006 | +1400.0% | 247.76M | +24.4% | 1 |
| Next quarter | 0.22 | 0.22 – 0.22 | 0.036 | +511.1% | 272.66M | +34.3% | 1 |
| Current year | 0.47 | 0.47 – 0.47 | 0.252 | +86.5% | 949.39M | +14.1% | 1 |
| Next year | 1.30 | 1.30 – 1.30 | 0.47 | +176.6% | 1.23B | +29.6% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 13, 2024 | Baird | Maintained | Outperform | Outperform |
| Aug 11, 2023 | Credit Suisse | Upgrade | Neutral | Outperform |
| Jul 14, 2022 | Credit Suisse | Downgrade | Outperform | Neutral |
| May 16, 2022 | Credit Suisse | Maintained | — | Outperform |
| Apr 7, 2022 | Nomura Instinet | Downgrade | Buy | Neutral |
| Sep 17, 2021 | Vertical Research | Downgrade | Hold | Sell |
| Jan 31, 2020 | Lake Street | Upgrade | Hold | Buy |
| Jan 6, 2020 | Credit Suisse | Upgrade | Underperform | Neutral |
| Jul 12, 2019 | Roth Capital | Downgrade | Buy | Neutral |
| Nov 20, 2018 | Roth Capital | Downgrade | Buy | Neutral |
| Nov 9, 2018 | Credit Suisse | Downgrade | Outperform | Neutral |
| Oct 1, 2018 | Roth Capital | Upgrade | Neutral | Buy |
| Aug 16, 2018 | Macquarie | Downgrade | Outperform | Neutral |
| Mar 15, 2018 | Roth Capital | Downgrade | Buy | Neutral |
| Nov 27, 2017 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Nov 10, 2017 | Baird | Maintained | — | Outperform |
| Oct 11, 2017 | Mizuho | Downgrade | Buy | Neutral |
| Sep 28, 2017 | Lake Street | Upgrade | Hold | Buy |
| Aug 4, 2017 | Baird | Upgrade | Neutral | Outperform |
| Jul 14, 2017 | Oppenheimer | Downgrade | Perform | Underperform |
| Mar 10, 2017 | Morgan Stanley | Upgrade | Underweight | Equal-Weight |
| Mar 9, 2017 | Mizuho | Upgrade | Neutral | Buy |
| Feb 16, 2017 | Northland Capital Markets | Upgrade | Market Perform | Outperform |
| Feb 7, 2017 | Morgan Stanley | Downgrade | Equal-Weight | Underweight |
| Jan 30, 2017 | Baird | Downgrade | Outperform | Neutral |
| Jan 11, 2017 | Roth Capital | Downgrade | Buy | Neutral |
| Nov 7, 2016 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Sep 29, 2016 | Roth Capital | Initiated | — | Buy |
| Sep 26, 2016 | Nomura | Downgrade | Buy | Neutral |
| Jul 5, 2016 | Nomura | Upgrade | Neutral | Buy |